Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other financing activities: 2010-2025

Historic Other financing activities for Arrowhead Pharmaceuticals (ARWR) over the last 3 years, with Sep 2025 value amounting to $5.0 million.

  • Arrowhead Pharmaceuticals' Other financing activities was N/A to $5.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.8 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2025, which is 59.54% up from last year.
  • According to the latest figures from FY2025, Arrowhead Pharmaceuticals' Other financing activities is $5.0 million, which was up 59.54% from $3.1 million recorded in FY2024.
  • In the past 5 years, Arrowhead Pharmaceuticals' Other financing activities registered a high of $5.0 million during FY2025, and its lowest value of $3.1 million during FY2024.
  • Moreover, its 2-year median value for Other financing activities was $4.1 million (2024), whereas its average is $4.1 million.
  • Data for Arrowhead Pharmaceuticals' Other financing activities shows a peak YoY soared of 59.54% (in 2025) over the last 5 years.
  • Yearly analysis of 2 years shows Arrowhead Pharmaceuticals' Other financing activities stood at $3.1 million in 2024, then surged by 59.54% to $5.0 million in 2025.